Koretake Anami

Title: Koretake Anami: Innovator in Peptide Derivatives

Introduction

Koretake Anami is a notable inventor based in Nakatsu, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of peptide derivatives. With a total of 4 patents to his name, Anami's work has implications for treating various central nervous system disorders.

Latest Patents

One of Anami's latest patents focuses on histidyl peptide derivatives. These novel peptide derivatives possess stronger actions on the central nervous system, including antagonistic action against hypothermia and locomotor stimulant action. The derivatives and their pharmaceutically acceptable acid addition salts are useful as therapeutic medicaments for central nervous disorders such as impaired consciousness, depression, and hypomnesia, particularly in association with conditions like schizophrenia and senile dementia. Another significant area of his research involves amino acid derivatives that inhibit prolyl endopeptidase.

Career Highlights

Throughout his career, Anami has worked with prominent companies such as Yoshitomi Pharmaceutical Industries, Ltd. and Japan Tobacco Inc. His innovative research has contributed to advancements in pharmaceutical applications, particularly in the treatment of neurological conditions.

Collaborations

Anami has collaborated with notable coworkers, including Itsuo Uchida and Kunio Iwata. Their combined expertise has furthered the development of effective therapeutic solutions.

Conclusion

Koretake Anami's contributions to the field of medicinal chemistry, particularly through his innovative peptide derivatives, highlight his role as a significant inventor. His work continues to influence the treatment of central nervous system disorders, showcasing the importance of innovation in healthcare.